R. Singla
6 Papers
R. Singla is an academic researcher. The author has contributed to research in topics: Medicine & Delphi method. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Clinical standards for drug-susceptible pulmonary TB
Onno W. Akkerman,Raquel Duarte,Simon Tiberi,H. Simon Schaaf,C. Lange,Jan-William C. Alffenaar,J. Denholm,A. Carvalho,Mathieu S. Bolhuis,Sergey Borisov,Judith Bruchfeld,A. Cabibbe,J.A. Caminero,Isabel Carvalho,Jeremiah Chakaya,Rosella Centis,Margareth Dalcomo,L. D Ambrosio,M. Dedicoat,Keertan Dheda,Kelly E. Dooley,J Furin,José Mª García-García,N. A. H. Van Hest,Bouke C. de Jong,Xhevat Kurhasani,Anne-Grete Märtson,Stellah G. Mpagama,Marcela Muñoz Torrico,Elizabete Nunes,Chee Wui Ong,Domingo Palmero,Rovina Ruslami,Antonia Morita Iswari Saktiawati,C. Semuto,Daniela Rosa da Silva,R. Singla,Ivan Solovic,Shobha Srivastava,Jurriaan E. M. de Steenwinkel,Al Story,Marieke G G Sturkenboom,Marina Tadolini,Z Udwadia,Anna Verhage,J. Zellweger,G. B. Migliori +46 more
TL;DR: These consensus-based clinical standards will help to improve patient care by guiding clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment for PTB.
18
Clinical standards for the management of adverse effects during treatment for TB
Kaleshwar Prasad Singh,A. Carvalho,Rosella Centis,L. D Ambrosio,G. B. Migliori,Stellah G. Mpagama,Ba-Cuong Nguyen,Rob E. Aarnoutse,Alena Aleksa,R. van Altena,P. K. Bhavani,Mathieu S. Bolhuis,Sergey Borisov,N. van 't Boveneind-Vrubleuskaya,Judith Bruchfeld,J.A. Caminero,Isabel Carvalho,J. Cho,Lina Davies Forsman,M. Dedicoat,Keertan Dheda,Karen Dooley,J Furin,José Mª García-García,A. Garcia-Prats,A. Hesseling,Scott K. Heysell,Y Hu,H. Y. Kim,Selene Manga,Ben J. Marais,Ioana Margineanu,AG Märtson,Marcela Muñoz Torrico,Heda Melinda Nataprawira,Elizabete Nunes,Chee Wui Ong,Domingo Palmero,Charles A. Peloquin,Ashley N. Rendon,Denise Rossato Silva,Rovina Ruslami,Antonia Morita Iswari Saktiawati,Prayudi Santoso,H. Simon Schaaf,Barbara J. Seaworth,Ush Simonsson,R. Singla,Alena Skrahina,Ivan Solovic,S. K. Srivastava,Sophie L. Stocker,Marieke G G Sturkenboom,Elin M. Svensson,Marina Tadolini,Tania A Thomas,Simon Tiberi,Jason A Trubiano,Z Udwadia,Anna Verhage,Dinh Hoa Vu,Onno W. Akkerman,Jan-William C. Alffenaar,Justin T Denholm +63 more
TL;DR: In this paper , the authors identified eight clinical standards to encourage best practice for the diagnosis and management of adverse effects (AE) to TB treatment cause morbidity, mortality and treatment interruption.
15
Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes.
Jonathon R. Campbell,Eward D. Chan,L. F. Anderson,Marion Bonnet,Sarah K. Brode,J. Peter Cegielski,Lorenzo Guglielmetti,R. Singla,Gregory J. Fox,Alena Skrahina,Denise Rodrigues,Liga Kuksa,Piret Viiklepp,Dick Menzies +13 more
Integrative proteomics and network biology approach to identify potential urine based biomarkers for tuberculosis.
S. Subramaniam,Anshul Varshney,R. Singla,Digambar Behera,Ranjan Kumar Nanda +4 more
TL;DR: In this paper , the authors used a robust multiplex technique to identify 131 proteins out of which 16 molecules showed at least two-fold change in tuberculosis (TB) diagnostics and identified a signature of three putative markers, leucine-rich alpha-2-glycoprotein (upregulated), roundabout homolog 4 and isoform 2 of prostatic acid phosphatase (downregulated).
Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis.
TL;DR: The elevated levels of IL-4+CD4+ T cells seen in patients may contribute to the downregulation of IFN-γ expression and the crucial effector function of CD4 T cells, leading to the persistence of disease and the immunopathology characteristically seen in Patients.